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Abstract
Introduction: We compared the ability of two devices estimating cardiac output from arterial pressure-curve analysis 
to track the changes in cardiac output measured with transpulmonary thermodilution induced by volume expansion 
and norepinephrine in sepsis patients.
Methods: In 80 patients with septic circulatory failure, we administered volume expansion (40 patients) or introduced/
increased norepinephrine (40 patients). We measured the pulse contour-derived cardiac index (CI) provided by the 
PiCCO device (CIpc), the arterial pressure waveform-derived CI provided by the Vigileo device (CIpw), and the 
transpulmonary thermodilution CI (CItd) before and after therapeutic interventions.
Results: The changes in CIpc accurately tracked the changes in CItd induced by volume expansion (bias, -0.20 ± 0.63 L/
min/m2) as well as by norepinephrine (bias, -0.05 ± 0.74 L/min/m2). The changes in CIpc accurately detected an 
increase in CItd ≥ 15% induced by volume expansion and norepinephrine introduction/increase (area under ROC 
curves, 0.878 (0.736 to 0.960) and 0.924 (0.795 to 0.983), respectively; P < 0.05 versus 0.500 for both). The changes in 
CIpw were less reliable for tracking the volume-induced changes in CItd (bias, -0.23 ± 0.95 L/min/m2) and 
norepinephrine-induced changes in CItd (bias, -0.01 ± 1.75 L/min/m2). The changes in CIpw were unable to detect an 
increase in CItd ≥ 15% induced by volume expansion and norepinephrine introduction/increase (area under ROC 
curves, 0.564 (0.398 to 0.720) and 0.541 (0.377 to 0.700, respectively, both not significantly different from versus 0.500).
Conclusions: The CIpc was reliable and accurate for assessing the CI changes induced by volume expansion and 
norepinephrine. By contrast, the CIpw poorly tracked the trends in CI induced by those therapeutic interventions.
Introduction
Cardiac output is regarded as one of the most important
variables to be monitored in patients with acute circula-
tory failure [1]. PiCCO and Vigileo devices are two com-
mercially available monitors that estimate cardiac output
by analyzing the arterial pressure waveform. These tech-
niques are attractive because they provide a ready and
continuous measure of cardiac output and because they
do not require intracardiac catheterization [2]. Arterial
pressure waveform analysis is based on the physiological
principle that stroke volume is physiologically related to
the arterial pressure wave and aortic impedance.
Nevertheless, these two techniques differ in the way
they estimate aortic impedance. The PiCCO device pro-
vides an estimation of the cardiac index from an analysis
of the pulse contour (CIpc), but it does not estimate aor-
tic impedance because it calibrates CIpc from a measure-
ment of cardiac index obtained from transpulmonary
thermodilution (CItd), a technique that has demon-
strated a robust accuracy in comparison with pulmonary
artery thermodilution [3-9]. In contrast, the Vigileo
device provides an estimation of cardiac index from an
analysis of the pulse waveform (CIpw), but it does not
require any external calibration because it estimates aor-
tic impedance from certain characteristics of the arterial
p r e s s u r e  w a v e f o r m  a n d  f r o m  s o m e  d e m o g r a p h i c  d a t a
[10]. Some studies in cardiac surgery patients suggested
t h a t  C I p w  r e l i a b l y  m e a s u r e s  c a r d i a c  i n d e x  w h e n  c o m -
* Correspondence: xavier.monnet@bct.aphp.fr
1 AP-HP, Hôpital de Bicêtre, Service de Réanimation Médicale, 78, Rue du 
Général Leclerc, Le Kremlin-Bicêtre F-94270, France
Full list of author information is available at the end of the articleMonnet et al. Critical Care 2010, 14:R109
http://ccforum.com/content/14/3/R109
Page 2 of 11
pared with the pulmonary artery catheter-derived mea-
surement [11-15]. However, the reliability of the CIpw
has been questioned [16-21]. In particular, it has been
suggested that the uncalibrated pressure-waveform anal-
ysis would not reliably track the changes in cardiac out-
put when the arterial tone changes to a large extent [20]
or during hyperdynamic states [22-24]. This raises the
question of the suitability of CIpw for critically ill patients
with hemodynamic instability. In particular, the device
could perform differently if the changes in cardiac output
were related to volume expansion or to vasopressor
administration during septic shock.
Therefore, we assessed the respective abilities of CIpc
and CIpw to track the changes in CItd induced by volume
expansion or by norepinephrine in sepsis patients.
Materials and methods
Patients
After approval by our Institutional Review Board (Comité
pour la Protection des Personnes île-de-France VII), we
enrolled 80 patients who had circulatory failure of septic
origin in our medical intensive care unit. Acute circula-
tory failure was defined by the presence of one or more of
the following signs: (i) systolic arterial pressure ≤90 mm
Hg (or decrease in systolic arterial pressure ≥50 mm Hg
in known hypertensive patients); (ii) urinary flow ≤0.5
ml/kg/hr for more than 2 hours; (iii) tachycardia ≥100
beats/min; and (iv) skin mottling [25,26]. Patients' rela-
tives were informed about the study at the time the
patient was included. They were given a choice to refuse
the patient's participation at that time. If not, patients
were informed as soon as their mental status allowed, and
they were given the choice to withdraw their participa-
tion in the study.
In 40 of these patients (Group 1), the attending physi-
cian decided to administer fluid because the patient
showed some criteria predicting fluid responsiveness:
increase in cardiac index (CI) ≥10% during a passive leg-
raising test [27]; increase in cardiac index (CI) ≥5% dur-
ing an end-expiratory occlusion [28]; or, in cases with no
spontaneous triggering of the ventilator and no cardiac
arrhythmias, a pulse-pressure variation ≥13% [29]. In 40
different patients (Group 2), the attending physician had
decided to introduce norepinephrine or to increase its
dosage because the mean arterial pressure was <65 mm
Hg (or 75 mm Hg in known hypertensive patients) [30]
and the diastolic arterial pressure was low [31].
All patients had a catheter inserted into the internal
jugular vein and a catheter inserted into the femoral
artery (Pulsiocath for thermodilution; Pulsion Medical
Systems, Munich, Germany). The arterial line was
divided in two branches, one connected to a PiCCOplus
device (PiCCOplus v6.0; Pulsion Medical Systems,
Munich, Germany), and the other one connected to a
FloTrac/Vigileo device (FloTrac/Vigileo v1.10; Edwards
Lifesciences, Irvine, CA). This enabled the two devices
simultaneously to analyze the same sample of the arterial
pressure curve.
Interventions and measurements
Before each therapeutic intervention (that is, before
administering fluid infusion in Group 1 and before intro-
ducing/increasing norepinephrine in Group 2), we per-
formed a first set of hemodynamic measurements,
including heart rate, systemic arterial pressure, CItd,
CIpc, CIpw, and systemic vascular resistance (SVR). We
used the values of CIpc and CIpw that were automatically
displayed on the screens of the commercial devices. The
CIpc and CIpw displayed by the monitors are averaged
over a 12-second and 20-second rolling period, respec-
tively. We could not obtain the digital (unprocessed,
unfiltered, and nonaveraged) data from the devices. In
practice, the CIpc and CIpw values displayed by the mon-
itors were averaged over 10-second periods. The CItd
was measured by the PiCCOPlus device by injecting 15
ml of iced saline (<8°C) through the central venous line.
The injection was manually performed in triplicate, and
the values of CItd were averaged. Immediately after per-
forming thermodilution boluses, the values of CIpc were
measured, the arterial line being physically shared in Y
through taps toward the Vigileo and the PiCCO devices.
Because the thermodilution automatically calibrated the
pulse-contour analysis of the PiCCO device, CIpc was
identical to CItd at the starting time. The CIpw was car-
ried immediately before thermodilution to avoid interfer-
ence between the temperature drift and the accuracy of
the CIpw. The total SVR was estimated as mean arterial
pressure divided by CItd.
After the first set of hemodynamic measurements was
completed in Group 1, fluid loading was performed by
infusing 500 ml of saline over a 30-minute period. In
Group 2, norepinephrine was titrated, targeting a mean
arterial pressure of 65 mm Hg [30] (or 75 mm Hg in pre-
viously hypertensive patients). All other treatments were
kept unchanged during the therapeutic intervention. In
particular, the dosage of norepinephrine was kept con-
stant in patients of Group 1 who already received norepi-
nephrine, and volume expansion was not administered to
the patients of Group 2 during the study period.
A second set of hemodynamic measurements was car-
ried out again after the therapeutic intervention (that is,
at the end of fluid administration in Group 1 and 5 min-
utes after stabilization of mean arterial pressure was
obtained in Group 2). This set included heart rate, sys-
temic arterial pressure, CIpc, CIpw, CItd, and SVR. The
values of CIpc and of CIpw were recorded before the
CItd. Therefore, the value of CIpc was not automatically
calibrated by the thermodilution. For that recording, theMonnet et al. Critical Care 2010, 14:R109
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arterial line was shared in Y through a tap turned on to
both the Vigileo and the PiCCO devices.
For 10 patients of Group 1 and 10 patients of Group 2,
radial and femoral arterial catheters were simultaneously
in place. In these patients, hemodynamic worsening
required switching from a simple radial blood-pressure
monitoring to a more complete hemodynamic monitor-
ing like transpulmonary thermodilution.
Just after the femoral catheter insertion and before the
radial catheter ablation, we took the opportunity to have
both catheters in place for testing whether connecting the
Vigileo device to the radial or to the femoral arterial line
could provide different measures of cardiac output. For
this purpose, before and after the therapeutic interven-
tion, immediately after recording the CIpw obtained from
the femoral line, the Vigileo device was disconnected
from the femoral line and connected to the radial line,
and the CIpw obtained from the radial line was recorded.
In these same patients, we also tested whether splitting
the arterial line into two branches introduced differing
harmonic influences into the system that might influence
the monitors. For this purpose, before and after the thera-
peutic intervention, the CIpc and CIpw were recorded
again after turning on the tap sharing the femoral arterial
line, such that the lines directed to both devices were
alternatively closed.
Statistical analysis
All data were normally distributed (Kolmogorov-Smirnov
test), except CItd, CIpc, CIpw, and the dosage of norepi-
nephrine, and are expressed as median [25th to 75th per-
centile]. In each patient, we performed only one pair of
measurements (before/after therapeutic intervention).
Comparisons between values recorded before with values
recorded after therapeutic interventions were performed
in both groups by using a paired Student t test or a paired
Wilcoxon test, as appropriate. Comparisons between
Group 1 and Group 2 were performed with a two-tailed
Student t test or a Mann-Whitney U test, as appropriate.
We compared the relative changes of CIpc and of CIpw
with those of CItd during the therapeutic interventions
by a Bland and Altman analysis (for absolute changes)
and by linear regression analysis (for percentage
changes). We tested the ability of CIpc and CIpw to
detect an increase in CItd ≥ 15% by constructing receiv-
ing operating characteristics (ROC) curves. The area
under the ROC curves (expressed as mean (95% confi-
dence interval) were compared by using the Hanley-Mac-
Neil test. This analysis was also separately performed in
patients in whom the SVR changed (increased or
decreased) by >15% with the therapeutic interventions
and in patients in whom the SVR changed (increased or
decreased) by <15% with the therapeutic interventions
[32]. The values recorded before therapeutic interven-
tions were not compared, because at this time, the CIpc
was, by definition, identical to the CItd value because of
calibration. After the therapeutic interventions, we com-
pared the absolute values of CIpc and of CIpw with that
of CItd by a Bland and Altman analysis and calculated the
percentage error as 2 SD/mean [33].
The precision of each method was calculated from data
obtained from a sample made of the first 20 and the last
20 patients included in the study when arterial pressure
was stable. For CItd, we calculated the coefficient of vari-
ation (ratio of the standard deviation to the mean) for
each set of three consecutive thermodilution boluses and
then averaged it for the series of the 20 sets. For CIpc and
CIpw, we collected the 10 consecutive values of CI dis-
played on the monitor. We calculated the coefficient of
variation for each set and averaged it for the series of 20
sets [32].
A P value < 0.05 was considered significant. The statis-
tical analysis was performed by using Statview 5.0 soft-
ware (Abacus Concepts, Berkeley, CA).
Results
Patient characteristics
The characteristics of the patients at baseline are summa-
rized in Table 1. All patients had a circulatory failure of
septic origin. Twenty-four (60%) patients of Group 1
received norepinephrine at baseline at 0.41 (0.27 to 0.58)
μg/kg/min, and this dosage was kept constant during the
study period. In group 2, 29 (72%) patients received nor-
epinephrine at baseline at 0.45 (0.12 to 0.85) μg/kg/min,
and this dosage was increased to 0.64 (0.38 to 1.50) μg/
kg/min. In group 2, 11 (28%) patients did not receive nor-
epinephrine at baseline, and norepinephrine was intro-
duced at 0.13 (0.11 to 0.21) μg/kg/min. The second set of
measurements was recorded 27 (25 to 29) minutes after
the first set in Group 1 and 31 (26 to 33) minutes after the
first set measurement in Group 2.
Comparisons between CItd, CIpc, and CIpw in the whole 
population
Considering the population as a whole, the therapeutic
interventions significantly increased the mean arterial
pressure, CItd, CIpc, CIpw, and the SVR by 21 (5 to 38)%,
13 (6 to 22)%, 14 (4 to 20)%, 8 (0 to 18%), and 5 (-10 to
19)%, respectively.
The bias between the absolute changes in CIpc and
CItd induced by therapeutic interventions was -0.07 ±
0.73 L/min/m2. The coefficient of correlation between
the percentage changes induced by the therapeutic inter-
ventions in CIpc and in CItd was 0.73 (P < 0.05). After the
therapeutic intervention, the bias between the absolute
values of CIpc and CItd was -0.07 ± 0.36 L/min/m2, and
the percentage error was 22%.Monnet et al. Critical Care 2010, 14:R109
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The bias between the absolute changes in CIpw and
CItd induced by therapeutic interventions was -0.10 ±
1.40 L/min/m2. The coefficient of correlation between
the percentage changes induced by the therapeutic inter-
ventions in CIpw and in CItd was 0.006 (P = 0.11). After
the therapeutic intervention, the bias between the abso-
lute values of CIpw and CItd was -0.09 ± 0.94 L/min/m2,
and the percentage error was 61%.
Comparisons of CIpc and CIpw with CItd in Group 1 
(volume expansion)
In Group 1, the volume expansion significantly increased
the mean arterial pressure, CItd, CIpc, and CIpw by 9 (1
to 20)%, 14 (7 to 24)%, 10 (4 to 16)%, and 7 (0 to 18)%,
respectively. The SVR nonsignificantly decreased by -10
[0 to -16)% (Table 2).
The bias between the absolute changes in CIpc and
CItd induced by volume expansion was -0.20 ± 0.63 L/
min/m2. The coefficient of correlation between the fluid-
induced percentage changes in CIpc and in CItd was 0.72
(P < 0.05) (Table 3, Figure 1). An increase in CIpc ≥ 12%
detected an increase in CItd induced by volume expan-
sion with an sensitivity of 74 (49 to 91)% and a specificity
95 (76 to 99)% (area under the ROC curve was 0.878
(0.736 to 0.960), P < 0.05 vs. 0.500; Table 3, Figure 2).
After volume expansion, the bias between the absolute
values of CIpc and CItd was -0.19 ± 0.32 L/min/m2, and
the percentage error was 18%.
The bias between the absolute changes in CIpw and
CItd induced by volume expansion was -0.23 ± 0.95 L/
min/m2. The coefficient of correlation between the fluid-
induced percentage changes in CIpw and in CItd was 0.33
(P < 0.05) (Table 3, Figure 1). An increase in CIpw ≥ 8%
detected an increase in CItd induced by volume expan-
sion, with an sensitivity of 56 (33 to 80)% and a specificity
71 (48 to 89)% (area under the ROC curve, 0.564 (0.398 to
0.720), P = 0.48 vs. 0.500 and P < 0.05 vs. the AUC for
CIpc; Table 3, Figure 2). After volume expansion, the bias
between the absolute values of CIpw and CItd was -0.32 ±
1.03 L/min/m2, and the percentage error was 58%.
Comparisons of CIpc and CIpw with CItd in Group 2 
(introduction/increase of norepinephrine)
In Group 2, the introduction or increase of norepineph-
rine significantly increased the mean arterial pressure,
CItd, CIpc, CIpw, and the SVR by 21 (5 to 36)%, 13 (7 to
22)%, 10 (3 to 17)%, 8 (0 to 18)% and 19 (9 to 31)%,
respectively (Table 2).
The bias between the absolute changes in CIpc and
CItd induced by norepinephrine introduction/increase
was 0.05 ± 0.74 L/min/m2. The coefficient of correlation
between the norepinephrine-induced percentage changes
in CIpc and in CItd was 0.78 (P < 0.05) (Table 3, Figure 3).
An increase in CIpc ≥ 15% detected an increase in CItd
induced by volume expansion with a sensitivity of 93 (68
to 99)% and a specificity of 88 (69 to 97)% (area under the
ROC curve, 0.924 (0.795 to 0.983), P < 0.05 vs. 0.500;
Table 3, Figure 2). After the introduction/increase of nor-
epinephrine, the bias between the absolute values of CIpc
Table 1: Patient characteristics at baseline
Age (years) 59 (53 to 72)
Gender (M/F) 37:43
SAPS II 41 (37 to 80)
ARDS (n, %) 38 (47)
Source of infection
Pneumonia (n, %) 64 (80)
Peritonitis (n, %) 6 (7)
Endocarditis (n, %) 5 (6)
Fasciitis (n, %) 2 (3)
Unknown 3 (4)
CItd (L/min/m2) 3.1 (2.2 to 3.5)
Vasopressors
Norepinephrine (n, %) 53 (66)
Dosage of norepinephrine (μg/kg/min) 0.43 (0.21 to 0.71)
Dobutamine (n, %) 6
n = 80.
Data are expressed as median [25% to 75% interquartile] or as number (%).
SAPS, Simplified Acute Physiologic Score; ARDS, acute respiratory distress syndrome; MAP, mean arterial pressure; CItd, cardiac index 
measured with transpulmonary thermodilution.Monnet et al. Critical Care 2010, 14:R109
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and CItd was 0.05 ± 0.36 L/min/m2, and the percentage
error was 23%.
The bias between the absolute changes in CIpw and
CItd induced by norepinephrine introduction/increase
was -0.01 ± 1.75 L/min/m2. The coefficient of correlation
between the norepinephrine-induced percentage changes
in CIpw and in CItd was -0.003 (P = 0.65) (Table 3, Figure
3). An increase in CIpw ≥ 34% detected an increase in
CItd induced by volume expansion with an sensitivity of
27 (8 to 55)% and a specificity 96 (80 to 99)% (area under
the ROC curve, 0.541 (0.377 to 0.700), P = 0.66 vs. 0.500
and P < 0.05 vs. the AUC for CIpc; Table 3, Figure 2).
After the introduction/increase of norepinephrine, the
bias between the absolute values of CIpw and CItd was
0.01 ± 0.94 L/min/m2, and the percentage error was 60%.
Effects of changes in SVR on the agreement of CIpc and 
CIpw with CItd
Considering the whole population, the SVR increased by
5 (-10 to 19)%. The bias between the changes in CIpc and
CItd was not significantly correlated with the changes in
SVR. By contrast, the bias between the changes in CIpc
and CItd was significantly correlated with the changes in
SVR (r = 0.43; P < 0.05).
In the subset of patients in whom the SVR changed by
<15% (n = 36), the bias between the absolute changes in
CIpc and CItd was -0.07 ± 0.63 L/min/m2, and the bias
between the absolute changes in CIpw and CItd was -0.21
± 1.01 L/min/m2. The coefficient of correlation between
the percentage changes in CItd and CIpc was 0.64 (P <
0.05), and the coefficient of correlation between the per-
centage changes in CItd and CIpw was 0.47 (P < 0.05).
In the subset of patients in whom the SVR increased by
>15% (n = 44), the bias between the absolute changes in
CIpc and CItd was -0.08 ± 0.70 L/min/m2, and the bias
between the absolute changes in CIpw and CItd was -0.06
± 1.79 L/min/m2. The coefficient of correlation between
the percentage changes in CItd and CIpc was 0.78 (P <
0.05), and the coefficient of correlation between the per-
centage changes in CItd and CIpw was -0.15 (P < 0.05).
Effects of connecting the Vigileo device to the femoral or 
the radial arterial lines
Considering the 20 patients in whom the Vigileo was suc-
cessively connected to the radial and the femoral arterial
lines before and after the therapeutic intervention (40
pairs of measurements), the CIpw values measured from
the radial and the femoral lines were not statistically dif-
ferent (2.9 (2.6 to 3.1) vs. 2.8 (2.6 to 3.1) L/min/m2; bias, -
0.08 ± 0.40 L/min/m2). In these patients after the thera-
peutic intervention, the bias between the absolute values
of CIpc and CItd was -0.11 ± 0.22 L/min/m2, and the per-
centage error was 14%. After the therapeutic interven-
tion, the bias between the absolute values of CIpw
connected to the radial line and CItd was -0.47 ± 0.84 L/
min/m2, and the percentage error was 57%.
Effects of the mode of connection of the PiCCO and Vigileo 
devices on the femoral arterial line
Considering the 20 patients in whom the femoral arterial
line was alternatively directed toward the sole PiCCO or
Vigileo devices or directed in a Y to both, before and after
therapeutic interventions (40 pairs of measurements), the
CIpc was not different when the femoral arterial line was
c o n n e c t e d  o n l y  t o  t h e  P i C C O  d e v i c e  o r  w h e n  i t  w a s
Table 2: Evolution of hemodynamic parameters during therapeutic interventions
Group 1 Group 2
Baseline After volume expansion Baseline After introduction/increase of 
norepinephrine
Heart rate (beats/min) 105 (82-130) 100 (89-123) 92 (82-120) 95 (79-115)
MAP (mm Hg) 69 (67-75) 76 (70-85)a 52 (47-58)b 72 (64-78)a
CItd (L/min/m2) 3.2 (2.4-3.6) 3.7 (3.1-4.1)a 2.9 (2.1-3.5) 2.9 (2.5-3.7)a
CIpc (L/min/m2) 3.2 (2.4-3.6) 3.4 (2.8-4.0)a 2.9 (2.1-3.5) 3.0 (2.4-3.6)a
CIpw (L/min/m2) 2.9 (2.6-3.2) 3.2 (2.8-3.7)a 2.7 (2.5-3.0) 3.0 (2.8-3.3)a
SVRi (dyne/sec/m2/cm5) 1,741 1,355-2,267) 1,724 1,495-1,996) 1,832 (1,323-2,675) 2,229 (1,740-2,874)a
GEDVi (ml/m2) 649 (554-715) 725 (649-803)a 690 (602-474) 728 (674-790)a
n = 40 in Group 1, and n = 40 in Group 2.
Data are expressed as median (25% to 75% interquartile). aP < 0.05, before versus after intervention; bP < 0.05, Group 2 versus Group 1.
MAP, mean arterial pressure; CItd, cardiac index measured by thermodilution; CIpc, pulse contour-based cardiac index measured with the PiCCO 
device; CIpw, arterial-pressure waveform-based cardiac index measured with the Vigileo device; SVRi, systemic vascular resistance indexed for 
body surface; GEDVi, global end-diastolic volume indexed for body surface.Monnet et al. Critical Care 2010, 14:R109
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directed in a Y to the PiCCO and the Vigileo devices (3.1
(2.6 to 3.8) vs. 3.0 (2.8 to 3.9) L/min/m2; bias, 0.02 ± 0.31
L/min/m2). The CIpw was not different when the femoral
arterial line was connected only to the PiCCO device or
when it was directed in a Y to the PiCCO and the Vigileo
devices (2.9 (2.6 to 3.2) vs. 2.9 (2.6 to 3.2) L/min/m2; bias,
0.04 ± 0.38 L/min/m2).
Variation of CItd, CIpc, and CIpw
The coefficient of variation was 6.8% for the CItd, 1.8%
for CIpc, and 2.0% for CIpw.
Discussion
We have shown that the calibrated pulse contour-derived
CI accurately tracked the changes in CI induced by vol-
ume expansion and norepinephrine in sepsis patients. By
contrast, the uncalibrated arterial pressure waveform-
based CI tracked the changes in CI induced by those
therapeutic interventions with less accuracy. The more
the SVR changed, the less the uncalibrated arterial-pres-
sure waveform analysis was accurate for monitoring the
changes in CI.
Difference of the devices for the measurement of arterial 
waveform-derived cardiac output
Among the techniques that have been developed as an
alternative to the pulmonary artery catheter, transpulmo-
nary thermodilution has been demonstrated to be reliable
for measuring cardiac output as compared with classic
thermodilution [3-6,8,9] and we used it as a reference in
the present work.
Different commercial devices use the arterial-pressure
waveform analysis for providing a real-time estimation of
stroke volume and cardiac output. The PiCCO device cal-
culates stroke volume by measuring the area under the
systolic portion of the arterial-pressure curve and divid-
ing it by the aortic impedance. The latter is determined
by calibration against a measure of cardiac output by
transpulmonary thermodilution. In addition, this device
enables tracking the changes in arterial compliance. At
Table 3: Summary of the comparisons between the different techniques used for measuring cardiac index
Changes induced by volume expansion 
(Group 1)
Changes induced by introduction/
increase in norepinephrine (Group 2)
CIpc versus CItd
Bland-Altman analysis for the changes 
in absolute value
Bias, -0.20 ± 0.63 L/min/m2 Bias, -0.05 ± 0.74 L/min/m2
Linear regression for the changes in 
percentage
r = 0.72 (P < 0.05) r = 0.78 (P < 0.05)
Ability of CIpc to detect an increase in 
CItd ≥ 15%
Cut-off, CIpc increase ≥ 12% Cut-off, CIpc increase ≥ 15%
Specificity, 74 (49 to 91)% Specificity, 93 (68 to 99)%
Specificity, 95 (76 to 99)% Specificity, 88 (69 to 97)%
Area under the ROC curve, 0.878 (0.736 to 
0.960)
Area under the ROC curve, 0.924 (0.795 to 
0.983)
CIpw versus CItd
Bland-Altman analysis for the changes 
in absolute value
Bias, -0.23 ± 0.95 L/min/m2 Bias, -0.01 ± 1.75 L/min/m2
Linear regression for the changes in 
percentage
r = 0.33 (P < 0.05) r = -0.03 (P = 0.65)
Ability of CIpw to detect an increase in 
CItd ≥ 15%
Cut-off, CIpw increase ≥8% Cut-off, CIpw increase ≥34%
Sensitivity, 56 (33 to 80)% Sensitivity, 27 (8 to 55)%
Specificity, 71 (48 to 89)% Specificity, 96 (80 to 99)%
Area under the ROC curve, 0.564 (0.398 to 
0.720)a
Area under the ROC curve, 0.541 (0.377 to 
0.700)a
n = 40 in Group 1, and n = 40 in Group 2.
aP < 0.05 vs. CIpc.
CItd, cardiac index measured by transpulmonary thermodilution; CIpc, pulse contour-based cardiac index measured with the PiCCO device; 
CIpw, arterial pressure waveform-based cardiac index measured with the Vigileo device; AUC, area under the curve; ROC, receiving operating 
characteristics.Monnet et al. Critical Care 2010, 14:R109
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the time of calibration, arterial compliance is calculated
from the time constant of the pressure decay in diastole
(t) and SVR (compliance t/SVR). Then, compliance and
resistance are updated from beat to beat, according to a
proprietary algorithm that depends particularly on the
arterial pressure (P) and on dP/dt. A specific patient-cali-
bration factor (cal) (which is independent of compliance
and resistance) is added to the formula, which computes
the pulse-contour cardiac output [7]. This estimation of
cardiac output from the pulse-contour analysis has been
demonstrated as reliable by numerous studies in various
clinical settings [4-8,13,32,34-37].
The Vigileo device differs from the PiCCO device in
two main points. First, it does not take into account the
area under the systolic part of the arterial curve, but does
the standard deviation of the points contained by the
arterial curve in a beat. Second, it does not determine
aortic impedance from any external calibration of cardiac
output, but estimates it from pressure-waveform charac-
teristics, such as skewness and kurtosis, and from patient
demographic data (age, gender, height, and weight) [10].
Figure 1 Bland-Altman plots. (a, b) Bland-Altman plot for the changes (in absolute values) and correlation (for the percentage changes) induced by 
volume expansion on cardiac index obtained by transpulmonary thermodilution (CItd) and cardiac index obtained by the pulse-contour analysis (CIpc). 
(c, d) Bland-Altman plot for the changes (in absolute values) and correlation (for the percentage changes) induced by volume expansion on cardiac 
index obtained by transpulmonary thermodilution (CItd) and cardiac index obtained by the arterial pressure waveform analysis (CIpw). Bland-Altman 
plots: straight line, bias; dashed line: +2 SD/-2 SD limits of agreement); dashed line, correlation line.
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With the software we used in the present study, the esti-
mation of arterial compliance is updated on a rolling 60-
second average. Whereas some studies demonstrated an
acceptable agreement between CIpw and CI measured
either by pulmonary or transpulmonary thermodilution
[11-15,37], other studies reported conflicting results
[17,18,20,21,24]. In particular, it has been suspected that
CIpw could be inappropriate for estimating CI in the case
of low SVR [20,24] or when the arterial waveform
changes to a large extent [17]. The most recently com-
mercial version of the device demonstrated a poor ability
to measure CI in critically ill patients with hemodynamic
instability [16].
Accuracy of the two arterial-pressure waveform analyses 
for tracking changes in cardiac output
In the present study, the CIpc showed good accuracy in
tracking the CItd changes induced by the therapeutic
interventions. Moreover, it was able to detect correctly
t h e  i n c r e a s e s  i n  C I t d  o f  ≥ 1 5 %  i n  R O C  c u rv e  a n a l y s i s .
Interestingly, this ability was not altered by the level of
Figure 2 Receiver operating characteristic (ROC) curves. (a) ROC curves constructed for testing the ability of the changes in cardiac index ob-
tained by the pulse-contour analysis (CIpc) (straight line) and of the changes in cardiac index obtained by the arterial-pressure waveform analysis 
(CIpw) (dashed line) to detect an increase in cardiac index obtained by transpulmonary thermodilution (CItd) ≥15% induced by me expansion. (b) ROC 
curves constructed for testing the ability of the changes in cardiac index obtained by the pulse-contour analysis (CIpc) (straight line) and of the chang-
es in cardiac index obtained by the arterial-pressure waveform analysis (CIpw) (dashed line) to detect an increase in cardiac index obtained by trans-
pulmonary thermodilution (CItd) ≥15% induced by the introduction/increase in norepinephrine.
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t h e  c h a n g e s  i n  S V R ,  c o n f i r m i n g  w h a t  w e  r e c e n t l y
r e po rt e d  [ 3 2 ] .  I t  i s  n o t ew o rt h y  t h a t  w e  u s ed  t h e  m o s t
recent version of the device that has been improved for
tracking the changes in arterial impedance.
By contrast, in our sepsis patients, the uncalibrated
estimation of CI poorly tracked the short-term changes in
CItd during volume expansion and in those secondary to
norepinephrine introduction/increase. Furthermore, the
CIpw was unable detect correctly the changes in CItd ≥
15%, induced either by volume expansion or by norepi-
nephrine introduction/increase. The precision of CIpw
device was high (that is, the values of repeated CIpw mea-
surements were close) [38], but its accuracy compared
with that of CItd was low. We could not further investi-
gate the technical limitation that made the uncalibrated
estimation of CI inaccurate, because we could not analyze
all the components of the proprietary algorithm. Never-
theless, we found that the low accuracy of CIpw was
related to the magnitude of SVR changes: the more the
SVR changed, the higher the bias between the changes in
CIpw and CItd. This suggests that the limitation of the
system probably resides in an incorrect estimation of the
resistive component of the cardiovascular system. It must
be acknowledged that when the SVR did not change to a
large extent, the reliability of CIpw was acceptable and in
agreement with recent studies conducted in nonsepsis
patients [13,15,19,37]. By demonstrating that the CIpw
was identical when measured from the radial and femoral
arteries, we ruled out the possibility that the inaccuracy
of CIpw was related to the fact that the device was more
frequently connected to the femoral artery. Also, by
checking that the CIpc and CIpw were identical when the
femoral arterial line was connected to only one of the
devices or when it was split in a Y between the two
devices, we ruled out the influence of some damping phe-
nomenon of the arterial line on the results observed in
the whole population.
Limitations
First, the CIpc was calibrated at baseline such that before
therapeutic interventions, the CIpc was similar to the
CItd. In this regard, it could be considered that the CIpc
was advantaged compared with the CIpw. Nevertheless,
the calibration of the CIpc was performed only at base-
line and thus could not affect the comparison of the abil-
ity of CIpc and CIpw to track changes in CI induced by
the therapies.
Second, we did not use the pulmonary artery thermodi-
lution as a reference. Nevertheless, the accuracy of the
transpulmonary thermodilution to measure cardiac out-
Figure 3 Bland-Altman plots. (a, b) Bland-Altman plot for the changes (in absolute values) and correlation (for the percentage changes) induced by 
the introduction/increase in norepinephrine on cardiac index obtained by transpulmonary thermodilution (CItd) and cardiac index obtained by the 
pulse-contour analysis (CIpc). (c, d) Bland-Altman plot for the changes (in absolute values) and correlation (for the percentage changes) induced by 
the introduction/increase in norepinephrine on cardiac index obtained by transpulmonary thermodilution (CItd) and cardiac index obtained by the ar-
terial-pressure waveform analysis (CIpw). Plots: straight line, bias; dashed line: +2SD/-2SD limits of agreement); dashed line, correlation line.
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put has been repeatedly demonstrated [4-6,8,13,32,34-
37].
Third, we investigated the reliability of CIpc and CIpw
to track short-term changes in CI. If tested during a lon-
g e r  c a l i b r a t i o n - f r e e  p e r i o d  ( f o r  e x a m p l e ,  > 1  h o u r ) ,  t h e
reliability of CIpc could be less. Finally, we used the data
that were automatically displayed by both devices (that is,
after processing, filtering, and averaging). Thus, we could
not precisely analyze the reason that one device per-
formed differently. The filtering and averaging of data by
the devices also likely explained part of the low variability
of CIpc and CIpw.
Conclusions
The pulse contour-derived estimation of CI provided was
accurate for assessing the changes in CI induced by vol-
ume expansion and norepinephrine in sepsis patients. By
contrast, the uncalibrated estimation of CI by arterial-
pressure waveform analysis was not of sufficient accuracy
for monitoring CI changes in this setting. Whether a new
generation of the Vigileo device would perform better
than the current commercial model we used remains to
be demonstrated.
Key messages
• In septic shock patients, the pulse contour-derived
estimation of cardiac index correctly tracked the
changes in cardiac index induced by volume expan-
sion and norepinephrine.
• The pulse-wave analysis was less reliable for track-
ing the changes in cardiac index induced by those
therapeutic interventions.
• The ability of the pulse-wave analysis to track the
changes in cardiac index was poorer when the sys-
temic vascular resistance changed to a large extent.
• Whether more-recent versions of the devices could
perform differently should be assessed in further
studies.
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